Huang HX - Search Results

1

miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.

Huang YQ, Ling XH, Yuan RQ, Chen ZY, Yang SB, Huang HX, Zhong WD, Qiu SP. Huang YQ, et al. Among authors: huang hx. Mol Med Rep. 2017 Sep;16(3):2431-2438. doi: 10.3892/mmr.2017.6910. Epub 2017 Jul 4. Mol Med Rep. 2017. PMID: 28677791 Free PMC article.

2

Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.

Cai S, Chen R, Li X, Cai Y, Ye Z, Li S, Li J, Huang H, Peng S, Wang J, Tao Y, Huang H, Wen X, Mo J, Deng Z, Wang J, Zhang Y, Gao X, Wen X. Cai S, et al. Oncotarget. 2015 Feb 28;6(6):3904-17. doi: 10.18632/oncotarget.2880. Oncotarget. 2015. PMID: 25714010 Free PMC article.

3

Re: Ernesto R. Cordeiro Feijoo, Arjun Sivaraman, Eric Barret, et al. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes. Eur Urol 2016;69:214-20.

Yuan R, Huang H. Yuan R, et al. Eur Urol. 2017 May;71(5):e147. doi: 10.1016/j.eururo.2016.10.044. Epub 2016 Nov 9. Eur Urol. 2017. PMID: 27836417 No abstract available.

4

Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.

Huang Y, Huang H, Han Z, Li W, Mai Z, Yuan R. Huang Y, et al. J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404. J Nanosci Nanotechnol. 2019. PMID: 30486934

5

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL.

Lu Y, Li B, Huang H, Leng Q, Wang Q, Zhong R, Huang Y, Li C, Yuan R, Zhang Y. Lu Y, et al. Front Oncol. 2022 Dec 5;12:1020317. doi: 10.3389/fonc.2022.1020317. eCollection 2022. Front Oncol. 2022. PMID: 36582803 Free PMC article.

6

Lu Y, Wu J, Li X, Leng Q, Tan J, Huang H, Zhong R, Chen Z, Zhang Y. Lu Y, et al. Front Immunol. 2024 Oct 28;15:1471198. doi: 10.3389/fimmu.2024.1471198. eCollection 2024. Front Immunol. 2024. PMID: 39530098 Free PMC article.

7

A novel peptide targets CD105 for tumour imaging in vivo.

Li X, Huang X, Zhang J, Huang H, Zhao L, Yu M, Zhang Y, Wang H. Li X, et al. Oncol Rep. 2018 Nov;40(5):2935-2943. doi: 10.3892/or.2018.6643. Epub 2018 Aug 14. Oncol Rep. 2018. PMID: 30132552

8

Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188-3p/ARID5B/AR axis in prostate carcinoma.

Chen Z, Fu S, Shan Y, Li H, Wang H, Liu J, Wang W, Huang Y, Huang H, Wang J, Ding M. Chen Z, et al. Pathol Res Pract. 2022 Sep;237:154052. doi: 10.1016/j.prp.2022.154052. Epub 2022 Jul 30. Pathol Res Pract. 2022. PMID: 35939970

9

Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.

Lu X, Wang Z, Huang H, Wang H. Lu X, et al. J Oral Pathol Med. 2020 Oct;49(9):897-906. doi: 10.1111/jop.13050. Epub 2020 Jul 4. J Oral Pathol Med. 2020. PMID: 32512620

10

Identification of a peptide targeting CD56.

Huang H, Liu Y, Ouyang X, Wang H, Zhang Y. Huang H, et al. Immunobiology. 2020 Jul;225(4):151982. doi: 10.1016/j.imbio.2020.151982. Epub 2020 Jul 6. Immunobiology. 2020. PMID: 32747027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters